Paroxysmal nocturnal hemoglobinuria is an acquired hemolytic anemia associated with somatic mutations in the Xlinked gene PIG-A, which encodes a protein involved in the biosynthesis of glycosyl phosphatidylinositol anchors. To further elucidate the molecular basis of paroxysmal nocturnal hemoglobinuria, we have worked out a systematic and relatively rapid methodology to scan for mutations in the entire coding region of the PIG-A gene. By this methodology, we have identified 15 different somatic mutations in 12 patients. The mutations were spread throughout the entire AROXYSMAL NOCTURNAL hemoglobinuria (PNH) is an acquired hemolytic anemia associated, in all cases so far examined, with a mutation in the X-linked PIG-A gene."* The PIG-A protein is required for the assembly in the endoplasmic reticulum of glycosyl phosphatidylinositol (GPI) anchors, through which a variety of surface molecules are attached to the cell mernb~ane.~ The deficiency in GPIlinked proteins may be complete or partial, and frequently red blood cells (RBCs) with a partial GPI-anchor deficiency (PNH 11) as well as RBCs with complete GPI-anchor deficiency (PNH 111) are found in the same patient.'" The localization of the PIG-A gene on the X-chrornosome**" may explain why mutations responsible for PNH always occur in PIG-A, despite the fact that at least nine other genes (two of which have recently been mapped to autosomes) are involved in GPI-anchor synthesis.'*."
PIG-A-coding region.
Of the mutations, 10 caused frameshifts, 6 caused small deletions, 3 caused small insertions, and 1 caused deletion-insertion. Five single base pair substitutions caused three missense mutations, one nonsense mutation, and one defect in the donor splice site of intron 4. In each of 3 patients, two independent mutations were identified. The predominance of frameshift mutations may reflect selection for somatic mutations giving rise to clones with a completely nonfunctional PIG-A protein. 0 1995 by The American Society of Hematology.
Transplantation, with an initially negative Ham test was diagnosed before PNH (AA-PNH).
Quant$cation of GPI-linked surface proteins. Analysis of GPlanchored membrane proteins on RBCs, granulocytes (polymorphonuclear cells [PMN] ), and lymphocytes was performed as previously described by flow cytometry (FACscan; Becton Dickinson, Mountain View, CA) using monoclonal antibodies towards GPI-linked surface antigens (CD59, CD55, decay-accelerating factor (DAF], CD16, and CD48)." Cells in which GPI-linked proteins are completely absent were designated as PNH 111; cells in which GPI-linked proteins were significantly decreased were designated as PNH 11.
PNH cell lines. Production and analysis of Epstein-Barr virustransformed lymphoblastoid cell lines has been described elsewere." DNA extraction. Granulocytes and mononuclear cells were separated by centrifugation over a Ficoll gradient. RBCs were removed by hypotonic lysis. Genomic DNA was extracted separately from peripheral blood granulocytes and mononuclear cells by the sodium dodecyl sulfate proteinase-K method." When necessary, blood samples were shipped from other centers in adenine citrate dextrose (ACD) at room temperature and were processed within 48 hours. Alternatively, we obtained Ficoll-separated frozen cells or DNA extracted individually from granulocytes and mononuclear cells.
Characterization of PIG-A mutations. We undertook a systematic approach whereby the coding sequence of the PIG-A gene was amplified from genomic DNA in four different portions using intronic primers (Fig I) . Polymerase chain reaction (PCR) amplification, single-strand conformation analysis (SSCA), and heteroduplex analysis (HA) were performed as previously described.'~'."
Nucleotide (nt) sequencing. Nt sequencing was performed using the Sequenase Version 2.0 sequencing kit (US Biochemical Corp. Cleveland, OH). Nt sequencing was performed either by direct sequencing (DS) using biotinylated primers or by cloning into phage M13.' For the latter, 7 to 24 M13 clones of each amplification product were sequenced each time. To facilitate detection of nt changes, sequencing reactions were loaded track-by-track (see Fig  2) . To exclude PCR-artefacts, only changes in the PIG-A nt sequence found in at least 2 individual M13 clones were counted. If the mutation caused a change in a restriction site, the mutation was verified by the appropriate restriction enzyme digest. DNA from the patient's mononuclear cells served as an internal control to show that the mutation was not constitutional.
RESULTS

Phenotype analysis.
Of the 17 patients we have investigated (6 males and 11 females), 1 l had primary, or classic, PNH, whereas in 6 (2 males and 4 females) the diagnosis of AA had been made before that of PNH (AA-PNH). With respect to RBCs, flow cytometry analysis showed that 2 of 17 patients had only PNH I1 cells. In 7 patients, both PNH I1 and PNH 111 cells were observed, whereas in 8 patients Table 1 ). DNA analysis. To localize the mutation within the 1452-bp coding region of the PIG-A gene, we used HA and SSCA of PCR-amplified genomic DNA. Four and three mutations were localized to a specific DNA fragment by SSCA and by HA, respectively, whereas 8 were seen by both methods (Fig  3) . One mutation (HH15) was found through the loss of a recognition site for a restriction enzyme that we used for both SSCA and HA. In these 12 patients, the shifted DNA fragments were further analyzed by nt sequencing, leading to the identification of a total of 15 mutations ( Table 1) . We did not succeed in localizing the mutation in 5 patients by following this algorithm.
A total of 4 patients had small deletions, and 2 had small insertions. In all these cases, the effect of the mutations was to cause a frameshift in the PIG-A coding sequence, leading to a truncated protein. Three patients were found to have single base pair changes (2 single amino acid [aa] substitutions; 1 early stop codon; see Table 1 ). In each of 3 patients we found two mutations. In HH50, the two mutations, a single base-pair substitution and a deletiodinsertion causing a frameshift, were remarkably close within the gene. Because they were found on independent M13 clones, we can be certain that they were in different cell populations (Fig 4) . The same applies to the two mutations in patients HH24 and HH54.
To confirm that the mutations observed had arisen as somatic mutations, we tested for their presence in DNA from mononuclear cells, in which the PNH component is usually smaller than that of granulocytes and, therefore, can serve as individual internal controls. This criterion was met in all of the 15 mutations.
Constitutional changes in the PIG-A gene. In HH13 (female PNH patient) we found, in addition to the somatic mutation, a second change in the PIG-A gene. In contrast to the former, the latter was equally present in the patient's granulocytes and mononuclear cells. Sequence analysis showed that HH 13 was heterozygous for a cytidine-to-thymidine substitution at position nt 55, causing a single aa change from arginine to tryptophan at position aa 19 ' In this case, the analysis was performed on a PNH Ill-lymphoblastoid cell line (HH13/49P). The somatic mutation found was confirmed by t HH13 is heterozygous for the inherited 55 C-to-T substitution.
* In this case, we analyzed PNH Ill-lymphoblastoid cell line (HH1513P) because no granulocyte DNA was available. 
DISCUSSION
Screening for PIG-A mutations. Our aim was to develop a generally applicable strategy, which, in contrast to the previously used methodologies,"~' would also be suitable for identifying unknown PIG-A mutations in stored patient samples and in samples sent from long distances. The method described here is based on SSCA and HA of PCR-amplified genomic DNA fragments. We were mindful of the fact that ( l ) , because the PIG-A gene is located on the X-chromosome, only one of the two is affected in women only and (2) often a proportion of blood cells belong to the PNH clone. We chose to analyze granulocyte DNA because a large proportion of these cells is usually affected by the PNH abnormality and because they are easy to separate from mononuclear cells. Using this approach. we identified mutations in 12 of 17 PNH patients. HA was more sensitive in localizing frameshift mutations (8 of IO), whereas single base pair changes were identified equally well by either SSCA or HA. To also pinpoint the mutation in the remaining patients and to further increase the sensitivity of our screening method, we are currently investigating alternative conditions and choices of restriction fragments to be used for both SSCA and HA.
Individual mutations. In 12 patients, sequence analysis of the shifted DNA fragments showed 15 different mutations ( Table 1 ). The mutations were spread throughout the entire coding region without obvious clustering. In exon 2, the largest exon of the PIG-A gene, we found 9 mutations; in addition, 3 were identified in exon 3, 1 in exon 4, and 1 in exon 5.
The mutations identified were all different, and none was identical to the 9 mutations we described However, two of the mutations described here have also been reported recently by Yamada et al.' Both of these are C -+ T changes (in HH54 the C -+ T change is on the noncoding strand). This single base pair substitution occurs in CpG dinucleotides and could occur by deamination, to which methylcytidine is vulnerable. Consistent with this dinucleotide being a hot spot for mutation," examples of multiple mutation at CpG sites are frequent in mutation databases.
Multiple clones in individual patients. In 3 patients (HH24, HH50, and HH54), we identified two coexisting PNH clones with different mutations. In all 3 patients, the mutations were located on independent .M 13 clones of the cloned PCR product; therefore, the mutations must have arisen independently. The existence of two different PNH clones in a single PNH patient has now been reported in 6 different patients!.x We did not find any obvious clinical pattern that would predict the existence of two independent PNH clones. The only consistent finding was that both mutations identified accounted for a nonfunctional PIG-A protein (PNH I11 phenotype).
Considering the PNH phenotype of RBCs in our 12 patients, we find that 5 had, in addition to the PNH Ill, a PNH 11 RBC population ( Table l) . The mutations found in these patients accounted only for the PNH 111 cells. We can infer that these 5 patients must have an additional PNH clone with a distinct mutation accounting for the PNH TI phenotype; therefore, at least 6 of 12 PNH patients have at least two PNH clones. In addition, in patient HH24, in whom we have identified two PNH 111 mutations at the molecular level, a third PNH clone (PNH 11) must also be present. Thus, the majority of our PNH patients have more than one PNH clone that must have arisen independently and coexist with each other. This finding strongly supports the hypothesis of the relative growth or survival advantage of PNH cells in patients with PNH. As to why we have thus far only identified the mutation responsible for the PNH 111 phenotype in all in the PIG-A gene was found in these patients just as it was in patients with classical PNH. Of the 6 mutations identified in these 4 patients, 4 were single base pair substitutions. The number is too small for us to make any f i r m statement as to the difference in the nature of the mutations in the two groups.
Mutation pattern in the PIG-A gene compared with that in other genes. Because the database of PIG-A mutations in PNH has grown to a respectable size, it is now possible to compare its spectrum with that observed in other systems (see Table 2 ). For this comparison we have selected two tissue-specific genes (P-globin and factor VIII) and one housekeeping gene (glucose-6-phosphate dehydrogenase [G6PD]). Mutations in all of these genes cause relatively common inherited disorders (&thalassemia, hemophilia A. and G6PD deficiency, respectively).2"~2' We have also included the adenomatous poliposis coli (APC) gene, in which both inherited and somatic mutations contribute to the pathogenesis of colon c a r c i n~m a .~~
The most striking contrast is observed between PIG-A and G6PD.
In structural terms, G6PD mutations are virtually all single base pair changes that entail single aa replacements, whereas in the PIG-A gene the majority are insertion-deletion mutations that cause frameshifts. In functional terms, all G6PD mutants have some residual enzyme activity; therefore, it has been suggested that complete inactivation of this enzyme would not be compatible with human life." The closest similarity is between the somatic mutations in the APC gene and the somatic mutations in the PIG-A gene.
In conclusion, the spectrum of mutations in the PIG-A gene may reflect the combination of two facts; ie, the gene is housekeeping but its mutations are tissue-specific. We previously suggested that the PNH mutation may confer a relative selective advantage on hematopoietic cells with regard to growth or survival in the context of bone marrow f a i l~r e .~.~~ The predominance of null mutations probably reflects the fact that the total absence of GPI-linked proteins entails a relative survival or growth advantage of the affected cells that is greater than that when the deficiency of GPIlinked proteins is only partial.
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